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ABSTRACT: The small Indian mongoose (Her-
pestes auropunctatus) is a rabies reservoir in areas
of the Caribbean including Puerto Rico, but no
rabies vaccination program targeting this host
exists. We used two derivatives of iophenoxic acid
(IPA) to evaluate placebo oral rabies vaccine bait
uptake by mongooses in southwestern Puerto
Rico. We hand-distributed baits at an application
rate of 200 baits/km2 at three, 400 ha, sites during
autumn 2016 and spring 2017. Each site con-
tained 90–100 cage traps in a 100 ha central
trapping area. We used ethyl-IPA as a biological
marker during the autumn and methyl-IPA during
the spring. We live captured mongooses for 10
consecutive days, beginning 1 wk following bait
application. We obtained a serum sample from
captured mongooses and analyzed the sera for
ethyl- and methyl-IPA by liquid chromatography-
mass spectrometry. During autumn 2016, 63%
(55/87) mongooses sampled were positive for
ethyl-IPA. In spring 2017, 69% (85/123) of
mongooses were positive for methyl-IPA. Pooling
seasons, accounting for recaptures between years,
and disregarding marker type, 74% (133/179)
unique mongooses were positive for IPA bio-
marker, indicating bait consumption during either
the autumn, spring, or both trials. We conclude
that distributing baits at an application rate of 200
baits/km2 is sufficient to reach over 60% of the
target mongoose population in dry forest habitats
of Puerto Rico.
Key words: Herpestes auropunctatus, iophe-
noxic acid, oral rabies vaccination, Puerto Rico,
rabies, small Indian mongoose.
The small Indian mongoose (Herpestes
auropunctatus) is a rabies reservoir on several
Caribbean islands (Seetahal et al. 2018) and
accounts for over 50% of animal rabies cases
in Puerto Rico (Ma et al. 2018). In Puerto
Rico, the first laboratory confirmed case of
rabies in mongooses was in 1950 (Tierkel et al.
1952). There have been two documented
human fatalities from mongoose-related ra-
bies in Puerto Rico in the 21st century: the
first in 2003, the most recent in 2015 (Ma et
al. 2018).
Control of rabies virus circulation in wild
carnivore populations is cooperatively man-
aged by state and local public health depart-
ments and the US Department of Agriculture
National Rabies Management Program, prin-
cipally using a strategy of oral rabies vaccina-
tion (ORV; Slate et al. 2005). However, no
ORV program targeting mongooses exists in
the Caribbean. Oral rabies vaccine develop-
ment research for mongooses was conducted
in the early 2000s (Blanton et al. 2006) and
evaluated the efficacy of the vaccinia-rabies
glycoprotein RABORAL V-RGt (Boehringer
Ingelheim Animal Health, Athens, Georgia,
USA) and an experimental recombinant rabies
virus vaccine (SPBNGA-S). Results from
Blanton et al. (2006) suggest that RABORAL
V-RG is not efficacious for mongooses, but
study subjects vaccinated with SPBNGA-S
seroconverted and survived a lethal challenge
with rabies virus. This research motivated the
development of a new vaccine with a similar
construct (SPBN GASGAS), which was later
reported to be immunogenic for mongooses
(Vos et al. 2013).
An effective ORV program requires a
vaccine-bait combination with proven efficacy
for the target species and safety for both
target and nontarget species. In addition,
recommended background ecological data
for target and nontarget species include
population densities and natural levels of
452
rabies virus neutralizing antibodies (RVNAs)
in target populations, as well as an effective
vaccine delivery system (appropriate bait
shape, flavor, etc.). In Puerto Rico, mongoose
population densities range from 0.44 to 0.75/
ha in select forested habitats (Johnson et al.
2016), and RVNA seroprevalence up to 39%
has been documented in some regions (Be-
rentsen et al. 2015). Bait preference trials
have been conducted (Berentsen et al. 2014,
2017), and recent research suggests rodents
(primarily black rats, Rattus rattus) are a
primary bait competitor (Berentsen et al.
2017). In Puerto Rico, mongooses breed
throughout the year, but two birth pulses
(March–April and July–August) are typically
observed with two to four pups per litter
(Pimentel 1955).
To demonstrate an effective vaccine-bait
delivery system and strategy, it is necessary to
measure bait uptake by the target species. In the
US, this is typically accomplished by evaluating
RVNA seroprevalence and bait biomarker
prevalence pre- and postbaiting in the target
population (Pedersen et al. 2019). Iophenoxic
acid (IPA) is a white, crystalline powder used as
a biological marker with numerous mammalian
species (Ballesteros et al. 2013). Laboratory
trials in mongooses found IPA concentrations in
serum remained above the level of quantifica-
tion for at least 8 wk postbait consumption
(Berentsen et al. 2019), which suggests suitabil-
ity as a short- to medium-term biological marker
to measure uptake in the field.
Our objective was to use two derivatives of
IPA: 2-(3-hydroxy-2,4,6-triiodobenzyl)buta-
noic acid (ethyl-IPA) and a methyl substituted
derivative (2-(3-hydroxy-2,4,6-triiodobenzyl)-
propanoic acid; methyl-IPA), to evaluate
placebo ORV bait uptake rates by free-ranging
mongooses following hand distribution at 2
baits/ha across three sites in southwestern
Puerto Rico during the autumn and spring.
We hypothesized that the targeted application
rate would be sufficient to reach at least 30%
of the mongoose population based on prelim-
inary bait disappearance studies with two
flavors of this placebo bait in the same study
areas and slightly lower application rate.
We conducted this study on the island of
Puerto Rico (Fig. 1). We established three
study plots: Salt Flats and Central Refuge on
the Cabo Rojo National Wildlife Refuge,
Cabo Rojo Municipality, and Escabi on
private land in Lajas Municipality (Fig. 2).
Dominant habitat type is classified as sub-
tropical dry forest (Diaz 2011). We conducted
this study during autumn 2016 and spring
2017 to accommodate potential seasonal bait
uptake differences as a result of differing
mongoose population densities between sea-
sons (Johnson et al. 2016).
Baits consisted of a 0.7 mL water-filled foil
blister pack surrounded by an outer bait matrix
FIGURE 1. Location of Puerto Rico in the Carib-
bean Sea relative to other nations in the region. The
black star represents the study location in southwest-
ern Puerto Rico.
FIGURE 2. Precise location of the Central Refuge,
Salt Flats, and Escabi study sites in southwestern
Puerto Rico during the autumn 2016 and spring 2017
placebo oral rabies vaccination bait applications.
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composed of gelatin and powdered chicken egg
(Ceva Sante´ Animale, Dessau–Rosslau, Ger-
many), a preferred bait flavor in field and
laboratory trials (Vos et al. 2013; Berentsen et
al. 2018). The outer bait matrix contained 2.8
mg of either ethyl-IPA (autumn 2016) or
methyl-IPA (spring 2017). We established a
400 ha baiting plot at each location, consisting
of a 100 ha central trapping area, surrounded
by a 500 m buffer zone. We hand-distributed
baits throughout each plot at an application
rate of 2 baits/ha by walking along eight, 2 km
transects, 250 m apart and deposited a single
bait every 20 m. All trap and bait locations
were predetermined and loaded onto a hand-
held GPS unit. We distributed baits in the
morning about 1 h after sunrise to maximize
bait availability to diurnal mongooses and
reduce potential nontarget bait consumption
by nocturnal rodents. Trapping commenced
7–9 d following bait application.
We live captured mongooses in 15315363
cm cage traps (Tomahawk Trap Company,
Hazelhurst, Wisconsin, USA) baited with
canned tuna. We placed 100 traps (10310
grid) at the Salt Flats and the Central Refuge
and 90 (5318 grid) at Escabi. We placed traps
100 m apart during the morning and checked
them daily for 10 d. We anesthetized captured
mongooses via intramuscular injection of 5 mg/
kg Telazol (tiletamine/zolazepam; Kreeger and
Arnemo 2012). We marked each mongoose by
subcutaneous injection of a uniquely num-
bered passive integrated transponder tag (Avid
Identification Systems, Norco, California,
USA) to identify recaptures. We collected
about 1 mL of whole blood by venipuncture
of the cranial vena cava (Briscoe and Syring
2004). We centrifuged blood samples in serum
separator tubes at 670 3 G for 15–20 min,
decanted the serum into cryovials, and stored
them at20 C and then80 C until analysis.
We tested individual mongoose serum for
methyl-IPA and ethyl-IPA using the liquid
chromatography-mass spectrometry method
described in Berentsen et al. (2019) with the
following modifications: we used propyl-IPA
as the surrogate analyte to quantify both
methyl-IPA and ethyl-IPA. For propyl-IPA,
the quantifier MRM (multiple reaction mon-
itoring) transition was 584.7456.8, fragmen-
tor 89 V, and collision energy 14 V. For ethyl-
IPA, the qualifier MRM transition was
570.7126.8, fragmentor 87 V, and collision
energy 61 V. Control mongoose serum was
fortified with both methyl-IPA and ethyl-IPA
at 1.3, 31, and 83 lg/mL (n¼27). Percent
recoveries for methyl-IPA ranged from 105%
to 118%, and 98.5% to 118% for ethyl-IPA.
The signal-to-noise ratio was calculated from
the average baseline noise observed in nine
control sera, and the average peak height
observed in nine control sera fortified with 1.3
lg/mL me-/et-IPA. The detection limit was
estimated as the IPA concentration in serum
equivalent to three times the signal-to-noise
ratio. The detection limit was 0.042 lg/mL for
methyl-IPA and 0.041 lg/mL for ethyl-IPA.
Among 87 mongooses sampled during 2016,
63% (95% CI: 53–73%) were positive for ethyl-
IPA (Table 1). Among 123 mongooses sampled
during 2017, 69% (95% CI: 60–77%) were
TABLE 1. Total number of small Indian mongooses (Herpestes auropunctatus) captured across three study sites
during a 10 d period in autumn 2016 following the distribution of marked placebo baits at a rate of 200 baits/km2
in southwestern Puerto Rico. The number of mongoose sera obtained from captured animals and the subset
testing positive for the detection of the ethyl-iophenoxic acid (ethyl-IPA) placebo bait marker residue is reported.
Study locations included the Salt Flats and Central Refuge on the Cabo Rojo National Wildlife Refuge, Cabo
Rojo Municipality, and one plot on private land (Escabi) in Lajas Municipality.
Study site
Central refuge Salt flats Escabi Total
No. animals captured 38 39 23 100
No. sera collected and tested for biomarker 35 32 20 87
No. sera testing positive for ethyl-IPA 22 22 11 55
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positive for methyl-IPA, 48% (95% CI: 40–
58%) were positive for methyl- and ethyl-IPA,
and 77% (95% CI: 70–84%) were positive for
either or both biomarkers (Table 2). Pooling
samples across years and accounting for 31
recaptures that were sampled during both
years, we sampled 179 individual mongooses.
We counted each recapture as positive or
negative only once regardless of the sampling
year. Disregarding which IPA derivative was
found and classifying mongooses simply as
marked or unmarked, 74% (95% CI: 68–80%)
of 179 mongooses were positive for IPA.
Additional figures and capture details are
found in the Supplementary Material.
Bait uptake rates observed in this study
suggest an application rate of 2 baits/ha is
sufficient to reach over 60% of the mongoose
population in this habitat, consistent with the
general recommendation of 60–90% vaccina-
tion to interrupt rabies virus transmission in
some wildlife species (Thulke and Eisinger
2008). Additional studies optimizing vaccine
bait densities in other habitats and using
alternate distribution methods (including ro-
tary wing distribution and bait stations) can
enhance a future integrated ORV program
targeting mongooses in Puerto Rico.
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SUPPLEMENTARY MATERIAL
Supplementary material for this article is online
at http://dx.doi.org/10.7589/2019-03-077.
TABLE 2. The small Indian mongoose (Herpestes auropunctatus) capture/recapture results from spring 2017
after 1000 trap nights each at the Salt Flats and Refuge and 900 trap nights at Escabi. Also shown is the number
of animals positive for either or both iophenoxic acid (IPA) derivatives and those that were negative.
Study site
Central refuge Salt flats Escabi Total
Captured 53 43 39 135
Sampled 46 42 35 123
Positive ethyl-IPA 23 28 20 71
Positive methyl-IPA 26 36 23 85
Positive ethyl-IPA only 5 4 2 11
Positive methyl-IPA only 8 12 5 25
Positive ethyl- and methyl-IPA 18 24 18 60
Positive either ethyl- or methyl-IPA 31 40 25 96
Negative 15 2 10 27
Recaptures from 2016 14 9 7 30a
a The total number of recaptures at each site between years. The pooled number of recapture events across all sites was 31 as one
mongoose was captured at the Central Refuge in 2016 and at the Salt Flats (~4.0 km away) in 2017.
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